# Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease

> **NCT00260793** · PHASE3 · UNKNOWN · sponsor: **Agarwal, Pinky, M.D.** · enrollment: 20 (—)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Ropinirole Hydrochloride

## Key facts

- **NCT ID:** NCT00260793
- **Lead sponsor:** Agarwal, Pinky, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (—)
- **Last updated:** 2006-02-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00260793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00260793, "Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00260793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*